Derbac M Liquid 0.5%

Use Derbac M Liquid 0.5% exactly as directed by your pharmacist, prescriber or the patient information leaflet supplied with the product.

The treatment schedule for scabies is: Apply once, repeat after 7 days. Do not change the dose, frequency or duration unless advised by a clinician.

Apply thoroughly to the hair, scalp or skin exactly as the product instructions specify, observing the stated contact time before washing off. Repeat treatment at the recommended interval where required.

Use the aqueous formulation for scabies and follow the exact product instructions. Areas where treatment is washed away during the treatment period should be reapplied. Suitability should be checked in pregnancy, breastfeeding and young children.

If symptoms of scabies worsen, do not respond as expected or you develop a serious reaction, stop and seek appropriate clinical advice.

Derbac M Liquid 0.5% contains Malathion 0.5% as the main active ingredient or treatment component.

The exact formulation, excipients, device components or inactive ingredients can vary by manufacturer and pack supplied.

Always check the patient information leaflet or product instructions supplied with your specific pack, particularly if you have known allergies or intolerances.

Local irritation can occur. Keep the product away from the eyes and follow the exact contact-time and repeat-treatment instructions on the pack.

Use the aqueous formulation for scabies and follow the exact product instructions. Areas where treatment is washed away during the treatment period should be reapplied. Suitability should be checked in pregnancy, breastfeeding and young children.

Children under 2 years, crusted scabies, widespread disease, significant immune suppression, secondary skin infection or diagnostic uncertainty may require face-to-face medical assessment.

Stop treatment and seek urgent medical help for difficulty breathing, swelling of the face, lips or tongue, collapse or another severe allergic reaction.

Use only as directed on the pack or by the pharmacist, and seek clinical review if symptoms are severe, recurrent, atypical or not improving as expected.